Sonmez, Emine2026-07-012026-07-0120251756-46462214-9414https://doi.org/10.1016/j.jff.2025.107062https://hdl.handle.net/20.500.12684/23584Royal jelly (RJ) is a nutrient-rich secretion produced by honeybees, known for its wide range of physiological and pharmacological effects. Comprising a complex mixture of proteins, lipids, vitamins, minerals, polyphenols, and hormones, RJ exhibits significant therapeutic potential across multiple domains of health. Key bioactive constituents such as 10-hydroxy-2(E)-decenoic acid (10-HDA), major royal jelly proteins (MRJPs), royalisin, apisimin, and jelleins are central to its antimicrobial, anti-inflammatory, antioxidant, immunomodulatory, anticancer wound-healing, longevity-promoting, and anti-aging effects. By supporting tissue repair and regeneration, RJ shows promise for medical and therapeutic applications. This review highlights the molecular mechanisms behind RJ's diverse biological activities and underscores its potential as a multifunctional therapeutic agent. The findings emphasize the need for further clinical research to validate RJ's efficacy and integrate it into evidencebased medical practice.en10.1016/j.jff.2025.107062info:eu-repo/semantics/openAccessRoyal JellyBioactive ComponentsBiological FunctionsAntimicrobial ActivityAntioxidant EffectAnticancer ActivityRoyal Jelly in modern biomedicine: A review of its bioactive constituents and health benefitsArticle1342-s2.0-105020960800WOS:001600207300001Q1Q2